Publicis Groupe is “massively increasing the gap between us and our competitors” in terms of revenue growth and profit margin ...

Finn Partners has launched an AI-powered crisis training platform to help PR pros navigate the media landscape and counter ...

In the wake of January’s deadly wildfires, Los Angeles County leaders are weighing a disaster registry intended to help disabled and senior residents get connected to emergency responders to bring ...

Most of the 24 million people in Affordable Care Act health plans face a potential one-two punch next year — double-digit premium increases along with a sharp drop in the federal subsidies that most ...

According to recent findings from Lob’s 2025 State of Direct Mail: Consumer Insight Report, healthcare has emerged as one of the highest performing sectors in the direct mail space. This stems from ...

An Omnicom spokesperson confirmed that the 2025 MM+M Agency 100 honoree will soon be folded into Omnicom Health subsidiaries.

The latest inspection comes 2 1/2 years after the agency allowed Sun Pharma to keep shipping some drugs to Americans even ...

Whether Kennedy hands down a ban or one is passed on Capitol Hill, pharma marketing is set to undergo a significant ...

Novartis made one of the biggest investments in Cannes among pharma companies, sending approximately 20 people from the ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

This roundtable explores how pharma can realign its strategy to ensure visibility, resonance and results in today’s shifting ...

Precision for Medicine, a biomarker-driven clinical research and development company, recently unveiled its Big Five Fatigue ...